ASAM Level 3.7 Treatment for Severe Opioid Use Disorder

Assessment and Treatment Criteria

• The American Society of Addiction Medicine (ASAM) criteria recommend residential/inpatient treatment for patients with severe addiction and comorbidities who are at high risk of relapse, mental health crisis, or behavioral problems 1
• Patients with physical dependence on opioids who have an associated withdrawal syndrome require medically supervised withdrawal ("detoxification") 1
• The presence of multiple substance use disorders suggests the need for mental health screening and treatment, which can be provided in this setting 1
• The American Academy of Family Physicians recommends a comprehensive treatment plan including individual therapy, group therapy, and medication management for patients with severe opioid use disorder and multiple psychiatric comorbidities 1

Medication Management and Treatment Plan

• A structured buprenorphine tapering with medical supervision is necessary for patients with a history of medication misuse 2
• Lofexidine is an appropriate medication for opioid withdrawal symptom management 1
• A comprehensive treatment plan should include individual therapy, group therapy, and medication management to address both substance use and mental health disorders 1

Common Pitfalls to Avoid

• Underestimating withdrawal severity in patients with polysubstance use history and psychiatric comorbidities can lead to inadequate treatment 2
• Discharging patients too early before establishing adequate coping skills and medication stabilization can increase the risk of relapse 1
• Failing to address underlying trauma and psychiatric conditions that contribute to substance use can hinder recovery 2